Olendalizumab

(Synonyms: ALXN1007; Lendalizumab)
Customer Review

Based on 1 Customer Validation

Olendalizumab (ALXN1007) is a mouse-derived and humanized IgG2-G4-κ antibody, targeting to Complement protein C5a (Ki=60 pM). Olendalizumab targets the complement inflammatory pathway. Moreover, Olendalizumab can be used for research of complement mediated disorder caused by corona virus.

For research use only. We do not sell to patients.

  • Purity: 97.43%
  • CAS No.: 2210314-30-8
  • Molecular Weight:146 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00